On the basis of these studies, it could be hypothesized that neonates who will develop a severe new BPD form, could benefit from an increase of the AAT antiprotease activity by areosolic or endovenous administration or by treatment with a catalytic antioxidant. This evidence concerns the gene SERPINA1 and bronchopulmonary dysplasia.